mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.03 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |